Session Type
Meeting
Search Results for covid
Abstract Number: 18
SHM Converge 2023
Case Presentation: Patient is a 45-year-old female with a history of esophageal reflux and dysmotility, asthma, depression/anxiety, and recent SARS-2-CoV infection (COVID-19) who presented to our hospital 9 months after initial and 3 months after recurrent COVID-19 with headache, dyspnea, and home blood pressures (BP) > 180/100. Patient reported intermittent symptoms for the last 3 […]
Abstract Number: 27
SHM Converge 2023
Case Presentation: This is a 4-year-old previously healthy girl, fully immunized with the exception of COVID-19 immunizations, who was hospitalized after presenting with fevers and fatigue for one week followed by gross hematuria. At the outset of her fevers, she tested negative for COVID-19 using a home antigen test. 4 days prior to admission, she […]
Abstract Number: 54
SHM Converge 2023
Background: Family members and caregivers serve valuable roles at the hospitalized patient’s bedside as emotional support systems, patient advocates, and decision makers (1). Hospital visitation restrictions (such as those implemented during the COVID-19 pandemic) may come at a cost to patient and caregiver perceptions of care quality and patient safety. Congruent with CDC guidelines during […]
Abstract Number: 99
SHM Converge 2023
Background: Since the start of the COVID-19 pandemic, racial and ethnic minorities have experienced disparities in infection rates, hospitalization, and death. Monoclonal antibodies (Mab) decrease hospitalization when given to ambulatory non-severe high-risk patients within 10 day of symptom onset. Disparities in care related to Mabs are not well understood. We describe experience from Mab infusion […]
Abstract Number: 101
SHM Converge 2023
Background: Transportation is a social determinant of health that can be a barrier to care and exacerbate disparities. During the COVID pandemic, access to transport was further diminished.Monoclonal antibodies (Mab) are associated decreased hospitalization in high-risk COVID patients. Until 9/2022, the $2000 cost per dose of Mabs was paid by the federal government. However transportation […]
Abstract Number: 104
SHM Converge 2023
Background: Physician burnout has been alarmingly high with over 50% of practicing physicians in the U.S. reporting burnout. Of which, general internal medicine displays some of the highest rates. A recent study was published in December 2021 examining the topic of burnout from the perspective of academic hospitalists at Froedtert Hospital and the Medical College […]
Abstract Number: 111
SHM Converge 2023
Background: Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant contributor to morbidity and mortality associated with COVID-19. In comparison to influenza, COVID-19 leads to a more pronounced hypercoagulable state secondary to endotheliopathy and hyperinflammatory state which results in the formation of venous and arterial thrombosis. Based on prior literature, patients with COVID-19 have […]
Abstract Number: 116
SHM Converge 2023
Background: Researchers across the globe have continued their effort in identifying important risk factors for severe COVID-19 infection. Patient demographics including age, race, gender, and certain chronic medical conditions including cardiovascular disease, diabetes, hypertension, and heart failure have been identified as the important risk factors for severity. To simply the risk stratification process, the CHA2DS2-VASc […]
Abstract Number: 120
SHM Converge 2023
Background: COVID-19 pandemic was vital in modifying healthcare delivery systems. This infection has led to variable composite outcomes in patients who have cardiovascular diseases [1,2]. In this study, we aimed to look into the impact of COVID-19 on incidence and outcomes of patients with Acute Myocardial Infarction using a nationally representative sample from the USA. […]
Abstract Number: 121
SHM Converge 2023
Background: Diabetic Ketoacidosis (DKA) is the most common severe acute complication of diabetes, and has shown to be worsened by COVID-191. Several studies have found an association between COVID-19 and worsened outcomes from diabetic ketoacidosis (DKA).2 Vaccination against COVID-19 has led to substantial declines in the frequency, severity, and mortality from acute infection, but little […]